ZYBERNO
Stock Report
Updated Jun 7, 2026

QTREX Quantum Ltd. (IINN)

Healthcare • NASDAQ

$1.42

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
QTREX Quantum Ltd. (IINN) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):GOOD (0.41x)
Operating Margin (Operational Efficiency):CRITICAL (0.0%)
Return on Capital (Capital Efficiency):CRITICAL (-468.3%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

QTREX Quantum Ltd. (IINN) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:1.42
Market Cap:$90.94M

Valuation Multiples (2)

P/B Ratio:39.15x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$88.26M
B. Profitability Assessment

Return Metrics (3)

Reinvestment Rate:0.5%
Fundamental Growth Rate (g):-2.2%

Margin Analysis (1)

Ebitda Margin:-4,661.9%

Yield Metrics (2)

Earnings Yield:-$999.00
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.56x
Quick Ratio:1.30x
Cash Ratio:1.12x

Leverage Analysis (3)

Debt To Equity Ttm:0.41x
Debt-to-Equity Ratio:0.41x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:1,587,000.00
Cash And Cash Equivalents:3,159,000.00
Long Term Debt:$194.00K
Net Debt:-$2.68M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

$289.00K
Cost Of Revenue Ttm:$287.00K

Profitability Breakdown (2)

$2.00K-$13.62M

Bottom Line Performance (3)

-$13.22M
Income Before Tax:-$13.22M
Ebitda Ttm:-13,473,000.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:7,496,000.00
Sga Expense:5,532,000.00
Income Tax Expense:$0.00
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:2,593.8%
Sga To Revenue Percentage:1,914.2%
Ebitda Margin:-4,661.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$5.34M
Current Assets:$4.41M
Ppe Net:452,000.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:3,018,000.00
Current Liabilities:2,824,000.00
Long Term Debt:$194.00K
Short Term Debt:$286.00K

Equity & Capital (3)

Equity:$2.32M
Retained Earnings:$0.00
Common Stock:100,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:735,000.00
Accounts Payable:0.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:3,575,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$9.86M-$9.96M

Investment Activities (1)

Investing Cash Flow:$565.00K

Financing Activities (3)

Financing Cash Flow:$7.33M
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:4,646,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:150,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (1)

Earnings Per Share Ttm:-$0.45

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.01
Operating Cash Flow Per Share:-$0.33

Book Value & Capital (2)

Book Value Per Share:$0.08
Cash Per Share:0.11

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.05x
Working Capital Turnover Ttm:0.18x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:0.39x
Days Inventory Outstanding Ttm:934.76

Payables & Cash Cycle (2)

Days Payable Outstanding:-999.00
Cash Conversion Cycle:934.76
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Damodaran Growth Analysis (2)

Reinvestment Rate:0.5%
Fundamental Growth Rate (g):-2.2%
B. Log-Linear Regression Growth Analysis
C. Company Profile & Context

Corporate Information (6)

Symbol:IINN
Company Name:QTREX Quantum Ltd.
Sector:Healthcare
Industry:Medical Devices
Exchange:NASDAQ
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:low
Volume Category:N/A

Share Structure (3)

Shares Outstanding:29.62M
Shares Outstanding Basic:29.62M
Shares Outstanding Diluted:29.62M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-06-07 21:10:58 UTC
Data Timestamp:2026-06-07T10:00:58.196840
Scroll to Top